Senti Biosciences Holdings, Inc. (SNTI) Form 8-K — Sep 24, 2026

$SNTIForm 8-KItems 5.02Filed Sep 24, 2026, 4:03 PM ET0001628280-26-063369Original filing

Senti Biosciences Holdings (SNTI) disclosed that director Brenda Cooperstone, Ph.D., resigned from the Board effective September 23, 2026. Dr. Cooperstone also stepped down as a member and Chair of the Compensation Committee, effective immediately.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.